The single-use bioreactors market is on a robust growth trajectory, with projections indicating it will surpass $9.1 billion by 2028. This impressive growth underscores the increasing adoption of single-use technologies in bioprocessing and the pivotal role they play in advancing the biotechnology and pharmaceutical industries.
Download an Illustrative overview:
Single-use bioreactors, also known as disposable bioreactors, have revolutionized the way bioprocesses are conducted by providing a cost-effective, flexible, and efficient alternative to traditional stainless-steel systems. Their popularity stems from their ability to minimize cross-contamination risks, reduce operational costs, and streamline manufacturing processes.
Key drivers behind this market surge include:
Increased Biopharmaceutical Production: The rise in demand for biopharmaceuticals, including monoclonal antibodies and gene therapies, has fueled the need for efficient and scalable production systems. Single-use bioreactors offer the flexibility to rapidly adapt to different production requirements.
Advancements in Technology: Continuous innovations in single-use bioreactor technology, such as improved control systems and enhanced materials, have expanded their applications across various stages of bioprocessing.
Cost Efficiency: The reduction in capital and operational expenditures associated with single-use systems compared to traditional stainless-steel alternatives is driving widespread adoption.
Regulatory Support: Favorable regulatory guidelines and growing recognition of single-use bioreactors' benefits are further accelerating their integration into bioprocessing workflows.
"Single-use bioreactors are transforming the landscape of bioprocessing," saidMarketsandMarkets. "Their scalability, efficiency, and cost-effectiveness are pivotal in meeting the increasing demands of the biopharmaceutical industry. As we move forward, we anticipate continued innovation and growth in this sector."
The single-use bioreactors market encompasses various segments, including upstream and downstream processes, with applications spanning cell culture, fermentation, and purification. As the bioprocessing industry evolves, single-use bioreactors are set to play an even more significant role in enhancing production capabilities and accelerating time-to-market for new therapies.
Content Source:
https://www.marketsandmarkets.com/PressReleases/single-use-bioreactor.asp
https://www.marketsandmarkets.com/ResearchInsight/single-use-bioreactor-market.asp
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek